HSBC Upgrades Copa Holdings to Buy

HSBC analyst Alexandre Falcao upgrades Copa Holdings (NYSE:CPA) from Hold to Buy.

byBenzinga Newsdesk

February 15, 2022

1 minute read

HSBC analyst Alexandre Falcao upgrades Copa Holdings (NYSE:CPA) from Hold to Buy.

Zealand Pharma Announces Presentation Of Preclinical Data On Amylin Analogue And Clinical Data On Glucagon-GLP1 Dual-Agonist At The Obesity Society Annual Meeting

By Benzinga Newsdesk

Today, 6:45 PM

Zealand Pharma A/S (NASDAQ:ZEAL) (CVR-no. 20045078,) a biotechnology company focused on the discovery, development and commercialization of innovative peptide-based medicines, today announced it will present preclinical

ZEAL

Analyst Ratings

What 4 Analyst Ratings Have To Say About Affiliated Managers Group

By Benzinga Insights

Today, 6:45 PM

Over the past 3 months, 4 analysts have published their opinion on Affiliated Managers Group (NYSE:AMG) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

AMG

A Philanthropic Activist Investor Maintains Stakes In 2 Canadian Railroad Stocks Paying Dividends

By Robert Kuczmarski

Today, 6:45 PM

British billionaire Chris Hohn is an activist investor who founded The Children's Investment (TCI) Fund Management in 2003. The fund manages The Children's Investment Master Fund.

CNI

Morgan Stanley Maintains Underweight on LegalZoom.com, Lowers Price Target to $7

By Benzinga Newsdesk

Today, 6:45 PM

Morgan Stanley analyst Elizabeth Porter maintains LegalZoom.com (NASDAQ:LZ) with a Underweight and lowers the price target from $9 to $7.

HSBC Upgrades Copa Holdings to Buy

Related Posts

Zealand Pharma Announces Presentation Of Preclinical Data On Amylin Analogue And Clinical Data On Glucagon-GLP1 Dual-Agonist At The Obesity Society Annual Meeting

What 4 Analyst Ratings Have To Say About Affiliated Managers Group

A Philanthropic Activist Investor Maintains Stakes In 2 Canadian Railroad Stocks Paying Dividends

Morgan Stanley Maintains Underweight on LegalZoom.com, Lowers Price Target to $7